Invirsa, Inc

Invirsa's lead compound, INV-102, stabilizes the innate reparative and energetic processes of the eye. The company has exciting Phase 2 data in Diabetic Dry Eye and has established a clear Regulatory path FDA for Phase 3 Development.

Address

Columbus
OH
United States
Visit website (opens in a new tab)
Loading